A statistically significant difference in NPX levels between benign tumors and borderline tumors + cancer was found for only two proteins, HE4 (WFDC2) and CA125 (MUC16) (conservative cut-off p < 0.001, p-values adjusted with False Discovery Rate (FDR)) (Table 6). Here, MUC16 is linked to cancer.